• Hill outreach on stopping the Medicare cuts and our advocacy agenda for 2024: protecting the financial viability of medical group practices, reducing prior authorization burden, advancing value-based care, improving quality reporting, maintaining access to care through telehealth, expanding the physician workforce, improving implementation of No Surprises Act requirements, and supporting the effective and ethical application of artificial intelligence technology. Telehealth: Submitted testimony to the House Committee on Ways and Means hearing, Enhancing Access to Care at Home in Rural and Underserved Communities. Laboratory developed tests: Submitted testimony to House Energy and Commerce Subcommittee on Health hearing on laboratory developed tests, Evaluating Approaches to Diagnostic Test Regulation and the Impact of FDAs Proposed Rule. Artificial intelligence: Submitted testimony to Senate Finance Committee hearing, Artificial Intelligence and Health Care: Promise and Pitfalls. Graduate medical education: Letter supporting the Substance Use Disorder Workforce Act (H.R. 7050). Information blocking: Submitted comments to CMS and ONC on the information blocking disincentives for providers proposed rule. Cybersecurity: Letter to HHS in response to the Change Healthcare cyberattack impact on medical groups. Medicare cuts rebilling clarification: Letter to CMS asking for rebilling clarification if Medicare cuts were retroactively addressed.

Duration: January 1, 2008 to November 2, 2015

General Issues: Medicare/Medicaid, Health Issues

Spending: about $17,696,228 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2008: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Consumer Financial Protection Bureau (CFPB), Occupational Safety & Health Administration (OSHA), Labor - Dept of (DOL), Small Business Administration (SBA), Health Resources & Services Administration (HRSA), Medicare Payment Advisory Commission (MedPAC), White House Office, Agency for Healthcare Research & Quality (AHRQ), Federal Trade Commission (FTC), Government Accountability Office (GAO), Justice - Dept of (DOJ), Office of Management & Budget (OMB), Agency for Health Care Policy & Research, Centers For Medicare and Medicaid Services (CMS), Justice - Dept of (DOJ), Health & Human Services - Dept of (HHS), President of the U.S., Administration on Aging, Substance Abuse & Mental Health Services Administration (SAMHSA), Office of Government Ethics (OGE), Congressional Budget Office (CBO), Office of Personnel Management (OPM), Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH)